Cargando…

High-resolution view of HIV-1 reverse transcriptase initiation complexes and inhibition by NNRTI drugs

Reverse transcription of the HIV-1 viral RNA genome (vRNA) is an integral step in virus replication. Upon viral entry, HIV-1 reverse transcriptase (RT) initiates from a host tRNA(Lys)(3) primer bound to the vRNA genome and is the target of key antivirals, such as non-nucleoside reverse transcriptase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ha, Betty, Larsen, Kevin P., Zhang, Jingji, Fu, Ziao, Montabana, Elizabeth, Jackson, Lynnette N., Chen, Dong-Hua, Puglisi, Elisabetta Viani
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096811/ https://www.ncbi.nlm.nih.gov/pubmed/33947853 http://dx.doi.org/10.1038/s41467-021-22628-9

Ejemplares similares

Advances in understanding the initiation of HIV-1 reverse transcription
por: Krupkin, Miri, et al.
Publicado: (2020)

Architecture of an HIV-1 reverse transcriptase initiation complex
por: Larsen, Kevin P., et al.
Publicado: (2018)

Heterogeneous structures formed by conserved RNA sequences within the HIV reverse transcription initiation site
por: Coey, Aaron, et al.
Publicado: (2016)

Identification of the Critical Sites of NNRTI-Resistance in Reverse Transcriptase of HIV-1 CRF_BC Strains
por: Huang, Yang, et al.
Publicado: (2014)

Clinical Implications of Mutations at Reverse Transcriptase Codon 135 on Response to NNRTI-Based Therapy
por: Tossonian, Harout K, et al.
Publicado: (2007)

Virtual screening, molecular docking studies and DFT calculations of FDA approved compounds similar to the non-nucleoside reverse transcriptase inhibitor (NNRTI) efavirenz
por: Jordaan, Maryam A., et al.
Publicado: (2020)

Crystal structures of a natural DNA polymerase that functions as an XNA reverse transcriptase
por: Jackson, Lynnette N, et al.
Publicado: (2019)

HIV-1 5’-Leader Mutations in Plasma Viruses Before and After the Development of Reverse Transcriptase Inhibitor-Resistance Mutations
por: Nouhin, Janin, et al.
Publicado: (2023)

Uncovering translation roadblocks during the development of a synthetic tRNA
por: Prabhakar, Arjun, et al.
Publicado: (2022)

1590. Resistance to Etravirine, Doravine and Rilpivirine in People Living with HIV Experiencing Virologic Failure to a First-line Antiretroviral Regimen Based on a Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) in a Latin American Country.
por: Mingrone, Verónica, et al.
Publicado: (2023)

NNRTI and Liver Damage: Evidence of Their Association and the Mechanisms Involved
por: Benedicto, Ana M., et al.
Publicado: (2021)

NMR characterization of HIV-1 reverse transcriptase binding to various non-nucleoside reverse transcriptase inhibitors with different activities
por: Thammaporn, Ratsupa, et al.
Publicado: (2015)

Cost-effectiveness of 2NRTI+NNRTI versus 2NRTI+PI as the initial cART regimen
por: Aragão, F, et al.
Publicado: (2010)

Mechanism of polypurine tract primer generation by HIV-1 reverse transcriptase
por: Figiel, Małgorzata, et al.
Publicado: (2018)

A reverse transcriptase ribozyme
por: Samanta, Biswajit, et al.
Publicado: (2017)

Reverse transcriptase activity in psoriatic lesions: effects of reverse transcriptase inhibitors on keratinocyte proliferation and differentiation
por: Molès, Jean-Pierre, et al.
Publicado: (2009)

Reverse Transcriptase and Cellular Factors: Regulators of HIV-1 Reverse Transcription
por: Warren, Kylie, et al.
Publicado: (2009)

Dolutegravir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Efavirenz Plus Two Nucleoside Reverse Transcriptase Inhibitors As Initial Antiretroviral Therapy for People with HIV: A Systematic Review
por: Rutherford, George W., et al.
Publicado: (2016)

Docking study of HIV-1 reverse transcriptase with phytochemicals
por: Seal, Abhik, et al.
Publicado: (2011)

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
por: Smith, Steven J., et al.
Publicado: (2014)

Asymmetric conformational maturation of HIV-1 reverse transcriptase
por: Zheng, Xunhai, et al.
Publicado: (2015)

HIV-1 Protease, Reverse Transcriptase, and Integrase Variation
por: Rhee, Soo-Yon, et al.
Publicado: (2016)

Approved HIV reverse transcriptase inhibitors in the past decade
por: Li, Guangdi, et al.
Publicado: (2022)

Fidelity of classwide-resistant HIV-2 reverse transcriptase and differential contribution of K65R to the accuracy of HIV-1 and HIV-2 reverse transcriptases
por: Álvarez, Mar, et al.
Publicado: (2017)

Low rates of nucleoside reverse transcriptase inhibitor and nonnucleoside reverse transcriptase inhibitor drug resistance in Botswana
por: Moyo, Sikhulile, et al.
Publicado: (2019)

NNRTI-induced HIV-1 protease-mediated cytotoxicity induces rapid death of CD4 T cells during productive infection and latency reversal
por: Trinité, Benjamin, et al.
Publicado: (2019)

Telomerase reverse transcriptase and neurodegenerative diseases
por: Yu, Xin, et al.
Publicado: (2023)

Reverse transcriptases prime DNA synthesis
por: Zabrady, Matej, et al.
Publicado: (2023)

Effect of reverse transcriptase inhibitors on LINE-1 and Ty1 reverse transcriptase activities and on LINE-1 retrotransposition
por: Dai, Lixin, et al.
Publicado: (2011)

Multiple dosage forms of the NNRTI microbicide dapivirine: product development and evaluation
por: Romano, Joseph
Publicado: (2006)

Rilpivirine versus etravirine validity in NNRTI-based treatment failure in Thailand
por: Teeranaipong, Phairote, et al.
Publicado: (2014)

Utilization of a Deoxynucleoside Diphosphate Substrate by HIV Reverse Transcriptase
por: Garforth, Scott J., et al.
Publicado: (2008)

Aptamers that recognize drug-resistant HIV-1 reverse transcriptase
por: Li, Na, et al.
Publicado: (2008)

The Role of Nucleotide Excision by Reverse Transcriptase in HIV Drug Resistance
por: Acosta-Hoyos, Antonio J., et al.
Publicado: (2010)

Aptamers that recognize drug-resistant HIV-1 reverse transcriptase
por: Li, Na, et al.
Publicado: (2009)

Cis-Allosteric Regulation of HIV-1 Reverse Transcriptase by Integrase
por: Masuda, Takao, et al.
Publicado: (2022)

Targeting the Structural Maturation Pathway of HIV-1 Reverse Transcriptase
por: Kirby, Thomas W., et al.
Publicado: (2023)

Retroviral Restriction Factor APOBEC3G Delays the Initiation of DNA Synthesis by HIV-1 Reverse Transcriptase
por: Adolph, Madison B., et al.
Publicado: (2013)

Long‐term outcomes of rapid antiretroviral NNRTI‐based initiation among Thai youth living with HIV: a national registry database study
por: Teeraananchai, Sirinya, et al.
Publicado: (2023)

Reverse Transcriptase Inhibitors Nanosystems Designed for Drug Stability and Controlled Delivery
por: Grande, Fedora, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kghsvs41amt46168lctd24u7dk